Structure of Upadacitinib CAS 1310726 60 3 - Upadacitinib CAS 1310726-60-3 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

1310726-60-3

Name

Upadac­i­tinib

Syn­onyms

(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluorethyl)-1-pyrrolidincarboxamid [Ger­man] [ACD/IUPAC Name] (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide [ACD/IUPAC Name] (3S,4R)-3-Éthyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroéthyl)-1-pyrrolidinecarboxamide [French] [ACD/IUPAC Name] (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide 10209 1310726-60-3 [RN] 1-Pyrro­­lidinecar­box­am­ide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)- [ACD/​Index Name] 4RA0KN46E0 ABT-494 UNII :4RA0KN46E0 UNII-4RA0KN46E0 upadac­i­tinib [INN] [USAN] upadac­i­tinib [Span­ish] [INN] upadac­i­tinib [French] [INN] upadac­i­tinibum [Latin] [INN] упадацитиниб [Russ­ian] [INN] 乌帕替尼 [Chi­nese] [INN] MFCD30502663

SMILES

CC[C@@H]1CN(C[C@@H]1c2cnc3n2c4cc[nH]c4nc3)C(=O)NCC(F)(F)F

Std­InChI

InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1

Std­InChIKey

WYQFJH­H­­DOK­W­SHR-MNOVXSKE­SA-N

Mol­e­c­u­lar Formula

C17H19F3N6O

Mol­e­c­u­lar Weight

380.368

MDL Number

MFCD30502663

Prop­er­ties

Appear­ance

Yel­low to off-white pow­der

Safe­ty Data

WGK Germany

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Upadac­i­tinib CAS 1310726-60-3

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR,HPLC

Puri­ty

≥99%

Ee By HPLC

≥99%

Heavy Met­als

≤0.002%

Loss on Drying

≤0.5%

Any indi­vid­ual impurity

≤0.5%

Total Impu­ri­ties

≤1.0%

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Upadac­i­tinib is a potent and selec­tive JAK inhibitor for the treat­ment of rheuma­toid arthri­tis.

Gen­er­al View of Documents

Upadacitinib CAS 1310726 60 3 EE HPLC - Upadacitinib CAS 1310726-60-3 Upadacitinib CAS 1310726 60 3 HPLC 1 - Upadacitinib CAS 1310726-60-3 Upadacitinib CAS 1310726 60 3 HNMR 1 - Upadacitinib CAS 1310726-60-3

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​u​p​a​d​a​c​i​t​i​n​i​b​-​c​a​s​-​1​3​1​0​7​2​6​-​6​0​-3/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly. 

























    Please prove you are human by select­ing the cup.